“Trastuzumab-Conjugated Nanoparticles: Design And Synthesis Of Trastuzumab-Conjugated Nanoparticles For Targeted Delivery Of Chemotherapeutic Agents To Her2-Positive Breast Cancer Cells”. Vascular and Endovascular Review 8, no. 12s (November 24, 2025): 310–315. Accessed June 10, 2026. https://verjournal.com/index.php/ver/article/view/957.